HIV test performed on USB stick
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The technology could enable patients with HIV to be managed more effectively in remote locations and can produce a result in under 30 minutes...
List view / Grid view
News
Increased protein activity makes bowel cancer drug resistant
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the National Cancer Research...
UK Artificial Intelligence firm signs license with Janssen for drug candidate
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
BenevolentAI, a British artificial intelligence company has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen...
Vasopharm appoints Irina Antonijevic as new Chief Medical Officer
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In this newly-created role, Dr Antonijevic will be responsible for advancing the clinical development of vasopharm’s lead ongoing program, VAS203...
€6 million for innovation in science, engineering and technology education
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The EU and the Swiss government gave €6.3 million for the Next-Lab project, which aims to bring changes in the way that science, engineering and technology are taught in Europe...
100 times more ‘love hormone’ than previously thought
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Oxytocin, which is produced in the hypothalamus in the brain, has a number of important functions in the body of mammals...
Anti-inflammatory drug reduces chance of pre-term birth
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers have found an anti-inflammatory drug that blocks certain inflammation pathways prevented pre-term birth entirely in pregnant mice...
Gut microbes linked to immunotherapy response in melanoma patients
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Patients with malignant melanoma are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to...
€3.2 million grant for medical fibre optics research
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The fibre optics research at KTH covers everything from bio-implants via medical sensors to solar cells and the researchers aim to have developed several...
‘Molecular commando’ identified to tackle hypoxic response
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers used pioneering techniques to develop a `small molecule’ chemical probe which offers highly targeted access to the hypoxic signalling pathway...
Artes and BioSun to co-develop on HPV vaccine
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The agreed long-term collaboration will take strengths from both companies to collaborate on the HPV vaccine although financial details of this agreement...
Targovax appoints of Øystein Soug as CEO
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Øystein Soug is the former CFO of Algeta, a Norwegian oncology biotech company which was sold to Bayer for USD 2.9 billion in 2014...
Newly discovered protein may hold key to better drugs for neglected diseases
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Bicyclic nitro-drugs used in the treatment of tuberculosis, including the recently approved drug delamanid, were reported as promising fast track options...
JangoBio launched to develop therapeutics for hormone replacement therapy
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
JangoBio announces their founding as a company focused on developing new therapies to sustainably reverse hormone imbalances associated with ageing...
TSRI study shows how Ebola adapted to better target human cells
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A new study csuggests that Ebola virus gained a genetic mutation during the 2013 – 16 epidemic that appears to have helped it better target human cells...